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Background: C5-epimerase converts a glucuronic acid to an iduronic acid residue in the heparan sulfate biosynthetic
pathway.
Results: C5-epimerase displays both “reversible” and “irreversible” catalytic modes.
Conclusion: C5-epimerase recognizes the saccharide sequence of the substrate to position the iduronic acid.
Significance: The biphasic catalytic mode of C5-epimerase reveals a unique control mechanism in the biosynthesis of heparan
sulfate.
Heparan sulfate (HS), a highly sulfated polysaccharide, is bio-
synthesized through a pathway involving several enzymes.
C5-epimerase (C5-epi) is a key enzyme in this pathway. C5-epi is
known for being a two-way catalytic enzyme, displaying a
“reversible” catalyticmode by converting a glucuronic acid to an
iduronic acid residue, and vice versa. Here, we discovered that
C5-epi can also serve as a one-way catalyst to convert a glucu-
ronic acid to an iduronic acid residue, displaying an “irreversi-
ble” catalytic mode. Our data indicated that the reversible or
irreversible catalytic mode strictly depends on the saccharide
substrate structures. The biphasic mode of C5-epi offers a novel
mechanism to regulate the biosynthesis of HS with the desired
biological functions.
Heparan sulfate (HS)4 is an essential glycan that is found on
the mammalian cell surface and in the extracellular matrix. HS
participates in a wide range of physiological and pathophysio-
logical functions, including embryonic development, inflam-
matory responses, blood coagulation, and viral/bacterial infec-
tions (1). HS consists of a disaccharide repeating unit of
glucuronic acid (GlcA) or iduronic acid (IdoA) and glucos-
amine, each of which is capable of carrying sulfo groups. The
biosynthetic pathway of HS includes HS polymerases, sulfo-
transferases, and C5-epi. Collective actions of these enzymes
result in matured HS with biological functions (supplemental
Fig. S1). Uniquely distributed sulfo groups and IdoA residues
play critical roles in determining the functions of HS (2); how-
ever, it remains unclear how to regulate the biosynthesis of
these specific sulfated saccharide sequences in vivo.
Understanding the biosynthetic mechanism also aids in
developing a chemoenzymatic method to synthesize HS-based
drugs. Heparin, a commonly used anticoagulant drug, is a spe-
cial form of HS with higher levels of sulfation and IdoA. Hepa-
rin is currently isolated from animal tissues through a long and
poorly regulated supply chain. Worldwide distribution of con-
taminated heparin in 2007 has raised the concerns over the
safety of animal-sourced heparins (3). A cost-effective method
to prepare synthetic heparin is desirable. UsingHS biosynthetic
enzymes, we developed a chemoenzymatic approach to synthe-
size structurally defined HS and heparin oligosaccharides in
high efficiency, which significantly expands the synthetic capa-
bility by a purely chemical approach (4, 5).
C5-epi converts a GlcA unit to an IdoA by forming a putative
carbanion intermediate at the C5-position of a GlcA unit (see
Fig. 1A) (6). Only a single isoform of C5-epi is in human
genome, and C5-epi knock-out mice are neonatal lethal, sug-
gesting its essential physiological roles in vivo (7). C5-epi
reportedly is a two-way catalytic enzyme, performing both the
forward and reverse epimerization. Namely, the IdoA unit
reverts back to a GlcA unit in the presence of C5-epi (8). The
nature of the reaction renders unique challenges to study the
mode of action of C5-epi. To date, three approaches have been
reported to measure the activity of C5-epi (9–11). Because all
these methods utilized structurally heterogeneous polysaccha-
ride substrates and the products were identified by a disaccha-
ride analysis, none of these approaches is capable of locating the
GlcA residues participated in the epimerization beyond a disac-
charide domain. Therefore, the understanding for the mecha-
nism of action of C5-epi was limited, especially the effects of
neighboring saccharide structures on the action of C5-epi.
In this article, we report an advancedmethod to characterize
C5-epi using a series of structurally defined oligosaccharide
substrates coupled with tandemmass spectrometry technique.
This method permits us to locate the number and position of
epimerization at the oligosaccharide levels with molecular pre-
* This work was supported in part by National Institutes of Health Grants
AI50050, HL094463, and GM072667 and National Science Foundation
Grant CHE-1111550.
□S This article contains supplemental “Methods,” Table S1, Figs. S1–S6, and
additional references.
1 Present address: Institute of Biochemical and Biotechnological Drug, School
of Pharmaceutical Science, Shandong University, Jinan, China.
2 To whom correspondence may be addressed: Dept. of Chemistry, Michigan
State University, East Lansing, MI 48824. Tel.: 517-355-9715 (ext. 329);
E-mail: xuefei@chemistry.msu.edu.
3 To whom correspondence may be addressed: Rm. 303, Beard Hall, Univer-
sity of North Carolina, Chapel Hill, NC 27599. Tel.: 919-843-6511; E-mail:
jian_liu@unc.edu.
4 The abbreviations used are: HS, heparan sulfate; C5-epi, C5-epimerase;
AnMan, 2,5-anhydromannitol; GlcA, glucuronic acid; IdoA, iduronic acid;
ESI, electrospray ionization; EPS, epimerization site; MRRS, mode of reac-
tion recognition site; AT, antithrombin.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 25, pp. 20996 –21002, June 15, 2012
© 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
20996 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 25 • JUNE 15, 2012
cision. On contrary to the convention view, we uncovered that
C5-epi also serves as a one-way catalyst to convert a GlcA to an
IdoA residue irreversibly, displaying an irreversible catalytic
mode. C5-epi recognizes the N-sulfation pattern of the sub-
strates to display reversible or irreversible catalytic mode of
C5-epi. The biphasic mode of C5-epi offers a novel mechanism
to regulate the biosynthesis of HS with the desired biological
functions.
EXPERIMENTAL PROCEDURES
Expression and Purification of C5-epi—Recombinant C5-epi
was expressed and purified as described previously (10). Briefly,
a fusion protein of maltose-binding protein and the human
C5-epi catalytic domain (Glu53–Asn617) was constructed in
pMal c2x vector (New England BioLabs). The expression was
carried out inOrigami-BDE3 cells (Novagen), which contained
pGro7 (Takara, Japan) plasmid expressing chaperonin proteins
GroEL andGroES ofEscherichia coli. The purification ofC5-epi
was completed using an amylose-agarose (New England Bio-
labs) column following the protocol provided by the manufac-
turer. To carry out the epimerization reaction in D2O buffer,
D2O-exchanged C5-epi was prepared. To this end, the har-
vested bacteria pellet were suspended in the buffer that was
prepared in D2O (99% D, Spectra Stable Isotopes). In addi-
tion, the elution buffers for amylose-agarose column purifica-
tion were also prepared in D2O.
The activity of purified C5-epi (including D2O-exchanged
C5-epi) was measured by coupling the reaction of C5-epi and
2-O-sulfotransferase (2-OST) followed by a disaccharide anal-
ysis (12). In this assay, C5-epi (1.5 g) was incubated with 2 g
of N-sulfo heparosan in the buffer containing 50 mM MES (pH
7.0), Triton X-100, and 1 mM CaCl2 at 37 °C for 30 min. To the
reaction mixture, 0.6 g of 2-OST and 3-phosphoadenosine
5-phospho[35S]sulfate ([35S]PAPS) (5–7  105 cpm) were
added. The reaction was incubated at 37 °C for two additional
hours. The 35S-labeled polysaccharide was purified by a DEAE
column and was then subjected to nitrous acid degradation (at
pH1.5) to yield the disaccharides. The identities of the resultant
disaccharides were determined by reverse-phase ion pairing
HPLC using a C18-column as described previously (13). As a
fully active C5-epi, 90% of resultant disaccharides from the
degraded polysaccharide have a structure of IdoA2S-AnMan,
where AnMan represents 2,5-anhydromannitol.
FIGURE 1. The reaction catalyzed by C5-epi and the schematic presentation for determining the activity of C5-epi. A shows the reaction catalyzed by
C5-epi. A trisaccharide segment of polysaccharide is shown. C5-epi removes the proton from C5 of the GlcA residue to form a putative carbanion intermediate.
An H2O molecule then reacts with the carbanion to form an IdoA residue. Conversely, C5-epi can catalyze the reverse reaction, namely to convert an IdoA
residue to a GlcA residue. B shows the schematic presentation for determining the activity and reversibility of C5-epi. The assay was developed based on the
reaction mechanism of C5-epi. Here, an oligosaccharide was used as a substrate. After incubation with C5-epi in D2O, the obtained epi-oligosaccharide had one
unit increase in Mr (MW), indicating that a single GlcA residue was converted to an IdoA residue. Tandem MS was used to locate the site of epimerization
because the epimerized residue should carry a deuterium. The reversibility of C5-epi was determined by incubating the epi-oligosaccharide with H2O. If the Mr
of the product reduces by one unit, the reaction was proved to be “reversible.” The Mr values of the oligosaccharides were determined by ESI-MS. The keys for
shorthand representations of carbohydrate residues are shown in the box.
TABLE 1
Reactivity and reaction modes of C5-epi toward the substrates with different structures






treatment in D2O Reaction mode
Octa-1b GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNAc-GlcA-AnMan 1554.3 1554.5  0.4 1556.4  0.3 Reversible
Octa-2c GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNS-GlcA-AnMan 1592.3 1592.4  0.4 1594.3  0.5 Reversible
Octa-3d GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-AnMan 1554.3 1554.5  0.4 1555.4  0.4 Irreversible
Octa-4e GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNAc-GlcA-AnMan 1516.3 1516.6  0.4 1517.6  0.5 Irreversible
Octa-5 GlcA-GlcNAc-GlcA-GlcNAc-GlcA-GlcNAc-GlcA-AnMan 1478.2 1478.5  0.2 1478.6  0.4 No reaction
Octa-6f GlcA-GlcNH2-GlcA-GlcNS-GlcA-GlcNS-GlcA-AnMan 1512.3 1512.2  0.4 1513.1  0.3 Reversible
Hexa-7g GlcA-GlcNS-GlcA-GlcNS-GlcA-AnMan 1175.0 1175.1  0.1 1175.9  0.1 Reversible
Deca-8h GlcA-GlcNAc-GlcA-GlcNS-GlcA(irreversible site)-
GlcNS-GlcA (reversible site)-GlcNS-GlcA-AnMan
1971.6 1971.2  0.4 1973.2  0.3 Reversible and irreversible
a The EPS sites are in boldface type.
b The data from the tandemMS analysis demonstrate that Octa-2 contains two EPS sites are shown in supplemental Fig S2.
c The data from the tandemMS analysis, which demonstrate that Octa-3 contains one irreversible EPS, are shown in Fig 3.
d The data from the tandemMS analysis, which demonstrate that Octa-4 contains one irreversible EPS, are shown in supplemental Fig S3.
e The data from the tandemMS analysis, which demonstrate that Octa-6 contains one reversible EPS, are shown in supplemental Fig S4.
f Only partial epimerization products were observed. The reaction was proved to be reversible.
g The data from the tandemMS analysis, which demonstrate that Deca-8 contains one irreversible EPS and one reversible EPS, are shown in supplemental Fig S4.
h The data from the tandemMS analysis, which demonstrate that Octa-1 contains two EPS sites, are shown in Fig 2.
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Preparation of Oligosaccharide Substrates—A total of eight
oligosaccharides, differing in the size of the oligosaccharides
and the distribution of N-sulfo groups, were prepared in this
study. The preparation of the substrates followed essentially the
same procedures described in our previous work (14–16). The
synthesis initiated from a disaccharide of GlcA-AnMan, which
was prepared fromnitrous acid, degraded heparosan. The elon-
gation from disaccharide to the desired size of oligosaccharide
substrates was completed by KfiA (N-acetyl glucosaminyl
transferase of E. coli K5 strain) and PmHS2 (heparosan syn-
thase 2 from Pasteurella multocida). In a typical elongation
reaction from the disaccharide to tetrasaccharide, 6 mg of
GlcA-AnMan was incubated with 18 mol of UDP-GlcNTFA
(UDP-N-trifluoroacetyl glucosamine) and 2mgofKfiA in 40ml
buffer containing 25 mM Tris-HCl, pH 7.2, 10 mM MgCl2 at
room temperature overnight. Upon the complete consumption
of UDP-GlcNTFA, 2 mg of PmHS2, and 27 mol of UDP-
GlcUA were added into the reaction mixture and allowed to
incubate overnight at room temperature. The product was
purified by a BioGel P-2 column (0.75  200 cm), which was
equilibrated with 0.1 M ammonium bicarbonate at a flow rate of
4 ml/h. The product fraction was located by electrospray ioni-
zationmass spectrometry (ESI-MS) analysis. For the additional
elongation reaction to the hexa-, octa-, and decasaccharides,
the conditions were identical essentially to the above, whereas
the reaction volumeswere adjusted to the smaller sizes depend-
ing on the amount of substrates. The conversion ofGlcNTFA to
GlcNS was performed under an alkaline condition to remove
the trifluoroacetyl group followed by N-sulfation using N-sul-
fotransferase and PAPS. We completed the synthesis of milli-
grams of each oligosaccharide substrates. The structures of the
oligosaccharides were confirmed by ESI-MS analysis.
The preparation of UDP-GlcNTFA was started from gluco-
samine (Sigma), which was first converted to GlcNTFA by
FIGURE 2. MS and MS/MS analysis of Octa-1 treated with D2O buffer with and without C5-epi. Octa-1 was incubated with D2O buffer with and without
C5-epi. The products were then subjected to MS and MS/MS analysis. A showed the ESI-MS spectrum of D-labeled epi-Octa-1, which was prepared by incubating
Octa-1 with D2O-exhanged C5-epi in D2O buffer. B showed the ESI-MS spectrum of Octa-1 that was treated D2O buffer without C5-epi. C showed the MS/MS
spectrum of D-labeled epi-Octa-1. Precursor ion selection was at [M  3H]3, m/z 517.90. D showed the MS/MS spectrum of Octa-1 that was treated with D2O
buffer only. Precursor ion selection was at [M  3H]3, m/z 517.30. The fragmentation pattern of MS/MS analysis is depicted on the top of C and D. Both the
fragment B5 (m/z value of 505.39) and C6 (m/z value of 615.88) of D-labeled epi-Octa-1 are 2 units higher than those of Octa-1 (the m/z value of 504.37 and
614.86), suggesting that the D-labeled residues are located at residue C and E in D-labeled epi-Octa-1. The product ions in the MS/MS data were labeled
according to Domon-Costello nomenclature (25).
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reacting with S-ethyl trifluorothioacetate (Sigma-Aldrich) fol-
lowed the protocol described previously (16). The resultant
GlcNTFA was converted to GlcNTFA-1-phosphate using
N-acetylhexosamine 1-kinase (17). The plasmid expressing
N-acetylhexosamine 1-kinase was a generous gift from Profes-
sor PengGeorgeWang (Georgia StateUniversity, Atlanta, GA),
and the expression of the enzyme was carried out in E. coli as
reported (17). The UDP-GlcNTFA synthesis was completed by
transforming GlcNTFA-1-phosphate using glucosamine-1-
phosphate acetyltransferase/N-acetylglucosamine-1-phos-
phate uridyltransferase as described (16). The protocols for the
expression of other HS biosynthetic enzymes and the prepara-
tion of PAPS were described elsewhere (16, 18). Additional
methods are presented under supplemental “Methods.”
RESULTS AND DISCUSSION
For the current work, eight structurally defined substrates
were synthesized using a chemoenzymatic approach (Table 1)
(4). AnMS-based method to monitor the reaction was devised,
which allowed us to pinpoint the epimerization site (EPS) and
to examine the reversibility of C5-epi. A substrate is incubated
with C5-epi and D2O, leading to an epimerized product with
deuterium incorporated. One unit of increase in molecular
weight (Mr) for epi-oligosaccharide suggests that one GlcA res-
idue is converted.Using a tandemMS technique, we located the
residue that carries the deuterium in the epi-oligosaccharide,
thus identifying the EPS site. The reversibility of the epimeriza-
tion is studied by incubating the deuterated epi-oligosaccharide
with C5-epi in H2O followed by MS analysis (Fig. 1B).
The reversibility of C5-epi was confirmed using Octa-1 as a
substrate, which has a structure of GlcA-GlcNS-GlcA-GlcNS-
GlcA-GlcNAc-GlcA-AnMan (Fig. 2). TheMr of epi-Octa-1was
increased to 1556.4 0.4 from 1554.5 0.3 (Table 1 and Fig. 2)
when it was treated with C5-epi in the presence of D2O. Fur-
thermore, the incubation of epi-Octa-1 with C5-epi in H2O
resulted in the decrease of itsMr by 1.9 units (from 1556.4 0.4
FIGURE 3. MS and MS/MS analysis of Octa-3 with and without the treatment of C5-epi. Octa-3 was incubated in the D2O buffer with and without C5-epi.
After incubation, the products were subjected to MS and MS/MS analysis. A shows the ESI-MS spectrum of Octa-3 that was treated with D2O buffer and
D2O-exchanged C5-epi. B shows the ESI-MS spectrum of Octa-3 that was treated in D2O buffer without C5-epi. C shows the MS/MS spectrum of D-labeled
epi-Octa-3. Precursor ion selection was at [M  3H]3, m/z 517.70. D shows the MS/MS spectrum of Octa-3. Precursor ion selection was at [M  3H]3, m/z
517.40. The fragmentation pattern of MS/MS analysis is depicted on the top of C and D. Both the fragment Y5 (m/z value of 499.23) and C6 (m/z value of 575.33)
of D-labeled epi-Octa-3 are 1.3 units higher than those of Octa-3 (m/z value of 498.57 and 574.67), suggesting that the D-labeled residue is located at residue
E in D-labeled epi-Octa-3. The product ions in the MS/MS data were labeled according to Domon-Costello nomenclature (25).
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to 1554.5 0.5).Our data suggest that twoGlcAunits inOcta-1
were susceptible to C5-epi modification, and both EPS sites
were reversible. These results were consistentwith the previous
report by Lindahl and co-workers (8).
Interestingly, C5-epi displayed an irreversible reaction mode
when a different substrate (Octa-3) was used, which has the struc-
ture of GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-AnMan.
Incubation of Octa-3 with C5-epi in D2O resulted in D-labeled
epi-Octa-3. D-labeled epi-Octa-3 exhibited theMr of 1555.4 
0.4 (Fig. 3A) with an increase of 0.9 units (Fig. 3B), suggesting
that a single GlcA residue was converted to IdoA. The Mr of
epi-Octa-3 remained unchanged after incubation with C5-epi,
suggesting that C5-epi was unable to reverse the reaction. To
further confirm the structure of D-labeled epi-Octa-3, a series of
experiments were conducted. Tandem MS analysis was
employed to prove that the D-labeled residue is located at resi-
due E. For example, the fragment Y5 of epi-Octa-3 (m/z value of
499.23 for the doubly charged ion) is 1.3 units higher than
that of Octa-3 (m/z value of 498.57) (Fig. 3, C and D). NMR
analyses of epi-Octa-3 confirmed the presence of IdoA at resi-
due E (supplemental Table S1). The presence of an IdoA in
epi-Octa-3 was also demonstrated after modifying epi-Octa-3
with 2-O-sulfotransferase followed by a disaccharide analysis
(supplemental data). High resolution ESI-MS analysis of D-la-
beled epi-Octa-3 showed a signal at a mass/charge ratio of
517.1121, consistent with [M  3H]3 of the anticipated struc-
ture (calculated mass/charge ratio, 517.1040).
Subjecting additional oligosaccharides to the analysis
revealed a relationship between the reaction mode of C5-epi
and the structures of substrates (Table 1). C5-epi appears to
recognize the flanking saccharide sequence at the nonreducing
end of the EPS residue. Oligosaccharides containing a nonre-
ducing end GlcNS residue immediately adjacent to the EPS
residue are reactive to C5-epi. In contrast, when the GlcNS is
replaced with GlcNAc (e.g. Octa-5), the oligosaccharide is no
longer a substrate of C5-epi, proving the critical role ofGlcNS at
the nonreducing end of the EPS (8).Whether C5-epi exhibits an
irreversible or a reversible mode depends on the residue at the
mode of reaction recognition site (MRRS) that is three residues
away from the EPS site toward the nonreducing end (Fig. 4A). If
a GlcNAc is present at the MRRS site, C5-epi displays an irre-
versible reactionmode (as forOcta-3 andOcta-4). If a GlcNS or
a GlcNH2 residue is present at the MRRS site (e.g. Ocat-1,
Octa-2, andOcta-6) or theMRRS site is unoccupied (i.e.Hexa-7
or the secondEPS site (EPS2) forOcta-1 and -2), C5-epi displays
a reversible reaction mode (Fig. 4A).
To further strengthen our conclusion, we synthesized a
decasaccharide substrate (Deca-8), permittingC5-epi to display
FIGURE 4. Reaction mode of C5-epi in response to different substrates. A summarizes possible reactions of C5-epi under the single reaction mode scenario.
The designated EPS is at the residue 0. The residue 1 must be a GlcNS residue to serve as an EPS site. The structure of the saccharide residue at the MRRS
determines the mode of reaction of C5-epi. If the MRRS site (residue 3) is a GlcNS or GlcNH2 residue or unoccupied, C5-epi displays a reversible reaction mode
(like reaction a, c, and b). If a GlcNAc residue is at the MRRS site, C5-epi displays an irreversible reaction mod (like reaction d). If residue 1 is a GlcNAc residue,
residue 0 is not an EPS site. B shows mixed reaction modes displayed by C5-epi when Deca-8 was used as a substrate. Two EPS sites were present in Deca-8. EPS1
is a reversible site, whereas EPS2 is an irreversible site. The gray shaded box indicates the saccharide residues recognized by C5-epi. The yellow shaded box
indicates the saccharide residues recognized by C5-epi during the mixed reaction modes. The keys for shorthand representations of carbohydrate residues are
shown in the box.
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mixed reaction modes (Fig. 4B). Here, two EPS sites were con-
structed at the residue 0 (EPS1) and residue 2 (EPS2), respec-
tively. Two MRRS sites were also introduced: a GlcNS and a
GlcNAc residue were placed at residue 3 and residue 5,
which should make a reversible EPS1 site and an irreversible
EPS2 site, respectively. Indeed, our data confirmed that EPS1 is
a reversible site, whereas EPS2 is irreversible (supplemental Fig.
S5).
Lastly, we tested the role of irreversible reaction mode of
C5-epi in contributing to the biosynthesis of HS that binds to
antithrombin (AT). HS or heparin forms a 1:1 complex with
AT, which deactivates the activities of factor Xa and IIa in the
blood coagulation cascade, to exhibit the anticoagulant activity.
Anticoagulant HS and heparin isolated from natural sources
have an AT-binding pentasaccharide with a structure of
-GlcNAc6S-GlcA-GlcNS3S6S-IdoA2S-GlcNS6S- (where
GlcNS3S6S representsN-sulfo glucosamine 3-O-sulfate with
or without 6-O-sulfate) (19, 20). The IdoA2S residue in the
pentasaccharide domain is known to be essential for high AT-
binding affinity (21).
The uncovered irreversible reactionmode of C5-epi provides
insight for the natural selection for a GlcNAc6S (not a
GlcNS6S) residue as part of the AT-binding site for its role in
positioning the IdoA residue. The GlcNAc residue is expected
to serve as a MRRS site to direct C5-epi to synthesize an irre-
versible IdoA residue in the AT-binding pentasaccharide site,
thus increasing the efficiency for the biosynthesis of AT-bind-
ing HS. To prove this assertion, the synthesis of AT-binding
decasaccharides was completed using three decasaccharide
substrates, including Deca-9, Deca-10, and Deca-11(supple-
mental Fig. S6). Deca-9 had no IdoA residue; Deca-10 con-
tained two reversible IdoA residues; and Deca-11 had one irre-
versible IdoA residue at EPS2 site and one reversible IdoA
residue at EPS1 site. The irreversible IdoA residue at EPS2 site
in Deca-11 was achieved by exposing Deca-10 to C5-epi modi-
fication. These decasaccharidesweremodified byO-sulfotrans-
ferases to produce O-sulfated decasaccharides and were then
fractionated by AT affinity columns to determine the amount
of AT-binding site in the products. The results revealed that
40% O-sulfated Deca-11 bound to the AT affinity column,
whereas the amount of theAT-binding portion forDeca-10was
determined to be 16%, a significant decrease in comparing to
that of Deca-11 (Fig. 5). As expected, only 4% of O-sulfated
Deca-8 bound to AT affinity column because it lacked an IdoA
residue. Taken together, our data suggest that an irreversible
IdoA residue at EPS2 site enhances the biosynthesis of AT-
binding site.
Conclusions—Although the biosynthesis of HS is not a tem-
plate-driven process, our results support the notion that HS
biosynthetic pathway adopts an exquisite way to fine tune the
extents of modifications through substrate control (22). Those
enzymes involved in modifying the highly sulfated substrates
(supplemental Fig. S1), i.e. 3-O-sulfotransferase, are able to dis-
tinguish the saccharide sequences with complicated sulfation
patterns (23). In contrast, the mechanism used by those
enzymes thatmodify the nonsulfated or low sulfated substrates,
including N-deacetylase/N-sulfotransferase and C5-epi, is per-
ceived to be subtle because the polysaccharide substrates have
relatively simple repetitive structures. In the initial N-sulfation
step, N-deacetylase/N-sulfotransferase introduces the GlcNS
residues consecutively, rather than randomly, along the poly-
saccharide substrate (24). Esko and Selleck (20) hypothesized
that the N-sulfation step introduces the codes to direct the
extent in the subsequent modification steps. Indeed, our find-
ings demonstrate that C5-epi recognizes the distribution of
GlcNS residues in the substrate and displays distinctive cata-
lytic modes, namely translating the N-sulfation code into the
positions of GlcA/IdoA residues. Our data clearly show the
impact of the irreversible mode of C5-epi on the efficiency for
the biosynthesis of anticoagulant HS. Further investigation will
unfold the full implication of the biphasic mode possessed by
C5-epi in controlling the biosynthesis of HS.
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